1. American College of Obstetricians and Gynecologists Committee on Practice Bulletins. Diagnosis and treatment of gestational trophoblastic disease. ACOG Practice Bulletin 53, June 2004, reaffirmed 2014.
2. Banet, N., DeScipio, C., Murphy, K. M., Beierl, K., Adams, E., Vang, R., & Ronnett, B. M. (2014). Characteristics of hydatidiform moles: Analysis of a prospective series with p57 immunohistochemistry and molecular genotyping. Modern Pathology, 27, 238–254.
3. Buza, N., & Hui, P. (2013). Partial hydatidiform mole: Histologic parameters in correlation with DNA genotyping. International Journal of Gynecological Pathology, 32, 307–315.
4. Vang, R., Gupta, M., Wu, L. S., Yemelyanova, A. V., Kurman, R. J., Murphy, K. M., Descipio, C., & Ronnett, B. M. (2012). Diagnostic reproducibility of hydatidiform moles: Ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis. American Journal of Surgical Pathology, 36, 443–453.
5. WHO Classification of Tumours Editorial Board. (2020). Female genital tumours (WHO classification of tumours series, 5th ed., Vol. 4). International Agency for Research on Cancer. https://publications.iarc.fr/592